Showing 871-880 of 5623 results for "".
What’s New in Dry Eye Management?
https://modernod.com/topics/ocular-surface/whats-new-in-dry-eye-management/38765/A look at our growing list of options.The Mystery of Cilioretinal Arteries and AMD
https://modernod.com/topics/retina/the-mystery-of-cilioretinal-arteries-and-amd/38788/Research is beginning to unravel the role these arteries play in the pathogenesis of neovascularization.Maximized Eye Health = Optimal Surgical Outcomes
https://modernod.com/mod-issues/2020-jan-feb/maximized-eye-health-optimal-surgical-outcomes/39095/Why it’s important to treat dry eye disease before cataract or refractive surgery.Meningioma Masquerader
https://modernod.com/editorial-series/complex-cases/meningioma-masquerader/54302/Compression of the optic chiasm mimics pituitary adenoma in this case.Allgrove Syndrome and the Eye
https://modernod.com/editorial-series/complex-cases/allgrove-syndrome-and-the-eye/56864/While rare, this condition can affect ocular health and must be managed accordingly.Treating Glaucoma in the Cataract Patient
https://modernod.com/mod-issues/2022-oct/treating-glaucoma-in-the-cataract-patient/38511/Combining treatments for both conditions has several benefits.Based on a presentation at MOD Live 2022 in Nashville, Tennessee.What To Do With a Pituitary Adenoma
https://modernod.com/topics/neuro-optometry/what-to-do-with-a-pituitary-adenoma/54412/A patient case provides insight on managing this type of benign tumor.Glaucoma Through a Legislative Lens
https://modernod.com/topics/glaucoma/glaucoma-through-a-legislative-lens/38552/Taking stock of the changing times and change in scope of practice for optometrists.Laser Therapy Then and Now
https://modernod.com/topics/retina/laser-therapy-then-and-now/37945/In the changing landscape of treatment options for diabetic eye disease, is there still a place for laser?Correcting High Myopia at the Nodal Point
https://modernod.com/mod-issues/2022-oct/correcting-high-myopia-at-the-nodal-point/39127/Redesigned with a central port, the latest version of the ICL is associated with better visual outcomes and less risk than earlier iterations of the lens.